Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cancer Clinical Trials: Survival Used As Endpoint 12% Of Time, FDA Reports

Jun 16 2003

• By The Pink Sheet

Related Content

FDA Revising Accelerated Approval Standard In Oncology; Biomarkers Sought

Jun 09 2003

Iressa Clears FDA: Phase IV Symptom Trial Will Be First Shot At Full Approval

May 12 2003

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window